Stay updated with our news

News

All
AI Assisted Diagnoses
Awareness Month
Counter
Digital Pathology Cases
Events
News
Presentations
Press Releases
Publications
Videos

Validation and 3 years of clinical experience in using an AI algorithm as a second read system for prostate cancer diagnosis
Prostate cancer ranks as the most frequently diagnosed cancer in men in the USA, with significant mortality rates.
Publications
CorePlus Expands Use of AI Tools to Routine Cancer Diagnosis
Back in June 2020, CorePlus Servicios Clínicos y Patológicos LLC (Carolina, Puerto Rico) became the first independent lab in the…
Publications
High risk HPV testing for cervical cancer screening in a Puerto Rican population
The human papillomavirus (HPV) is the principal cause of cervical cancer and can cause up to six different types of…
Publications
Comparative analysis of onychomycosis in Puerto Rico using molecularand conventional approaches
Onychomycosis is responsible for 50% of all nail infections. It is the most frequent nail ailment in adults and is…
Publications
CorePlus Announces the Deployment of Artificial Intelligence Algorithm for 100% QC of Pap Tests
CorePlus is the first laboratory in the world to operationalize the Techcyte AI algorithm.
Press Releases
Using AI in Pathology to Benefit Patients w/ Mariano de Socarraz
Watch this amazing conversation between Aleksandra Zuraw and Mariano de Socarraz discussing the transformative story of CorePlus.
Videos
Health Industry Summit 2024 by the Puerto Rico Manufacturers Association
Mariano de Socarraz, founder and CEO of CorePlus, during the Health Industry Summit 2024 of the Puerto Rico Manufacturers Association.…
Events
Unprecedented Patient Care: CorePlus Uses AI for 100% QC in Cervical Cytology
Insights into the shift from manual microscopy to digital diagnostics using Techcyte's AI platform.
Videos
CorePlus leading the way for AI adoption in digital pathology
Watch this interview with CorePlus CEO and CMO to learn why they have chosen to use AI in primary diagnosis.
Videos
CorePlus and Ibex show real world success with AI for routine cancer diagnosis
CorePlus and Ibex show real world success with AI for routine cancer diagnosis.
Publications